Apple Resumes Watch Sales with Blood Oxygen Features Disabled

Apple is once again selling its Watch Series 9 and Watch Ultra 2 in the US, but with the blood-oxygen monitoring features disabled. Apple is in the middle of a legal battle with Masimo over a patent on blood-oxygen monitoring technology. The most recent ruling was against Apple, but the company is appealing. A separate ruling affirmed that Apple could sell the watches with the disputed features removed or disabled. Apple was forced to pause sales of these models for a period that included some of the holiday shopping season. The feature is only disabled in new watches; existing watches are unaffected by this import and sales ban.